Company registration number 09164373 (England and Wales)
KULKARNI HEALTHCARE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
KULKARNI HEALTHCARE LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
KULKARNI HEALTHCARE LTD
BALANCE SHEET
AS AT
31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
47,739
39,223
Investments
5
26,026
25,405
73,765
64,628
Current assets
Debtors
6
-
0
1,371
Cash at bank and in hand
262,043
205,116
262,043
206,487
Creditors: amounts falling due within one year
7
(39,523)
(37,230)
Net current assets
222,520
169,257
Net assets
296,285
233,885
Capital and reserves
Called up share capital
104
104
Revaluation reserve
8
4,155
4,155
Profit and loss reserves
292,026
229,626
Total equity
296,285
233,885

The notes on pages 2 to 6 form part of these financial statements.

For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 March 2026 and are signed on its behalf by:
Mr S S Kulkarni
Dr N S Kulkarni
Director
Director
Company registration number 09164373 (England and Wales)
KULKARNI HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
1
Accounting policies
Company information

Kulkarni Healthcare Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 7 Lindum Terrace, Lincoln, Lincolnshire, England, LN2 5RP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. Modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
3 Year Straight Line
Motor vehicles
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

KULKARNI HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 3 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

KULKARNI HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
KULKARNI HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 5 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2024
96,092
Additions
23,949
At 31 August 2025
120,041
Depreciation and impairment
At 1 September 2024
56,869
Depreciation charged in the year
15,433
At 31 August 2025
72,302
Carrying amount
At 31 August 2025
47,739
At 31 August 2024
39,223
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
26,026
25,405
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 September 2024
25,405
Valuation changes
621
At 31 August 2025
26,026
Carrying amount
At 31 August 2025
26,026
At 31 August 2024
25,405
KULKARNI HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 6 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
1,171
Other debtors
-
0
200
-
0
1,371
7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
21,002
16,935
Other creditors
18,521
20,295
39,523
37,230
8
Revaluation reserve
2025
2024
£
£
At the beginning and end of the year
4,155
4,155
2025-08-31 2024-09-01 false false false 15 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr S S Kulkarni Dr N S Kulkarni 09164373 2024-09-01 2025-08-31 09164373 2025-08-31 09164373 2024-08-31 09164373 core:OtherPropertyPlantEquipment 2025-08-31 09164373 core:OtherPropertyPlantEquipment 2024-08-31 09164373 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 09164373 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 09164373 core:WithinOneYear 2025-08-31 09164373 core:WithinOneYear 2024-08-31 09164373 core:CurrentFinancialInstruments 2025-08-31 09164373 core:CurrentFinancialInstruments 2024-08-31 09164373 core:ShareCapital 2025-08-31 09164373 core:ShareCapital 2024-08-31 09164373 core:RevaluationReserve 2025-08-31 09164373 core:RevaluationReserve 2024-08-31 09164373 core:RetainedEarningsAccumulatedLosses 2025-08-31 09164373 core:RetainedEarningsAccumulatedLosses 2024-08-31 09164373 bus:Director1 2024-09-01 2025-08-31 09164373 bus:Director2 2024-09-01 2025-08-31 09164373 core:ComputerEquipment 2024-09-01 2025-08-31 09164373 core:MotorVehicles 2024-09-01 2025-08-31 09164373 2023-09-01 2024-08-31 09164373 core:OtherPropertyPlantEquipment 2024-08-31 09164373 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 09164373 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 09164373 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 09164373 bus:FRS102 2024-09-01 2025-08-31 09164373 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 09164373 bus:FullAccounts 2024-09-01 2025-08-31 xbrli:pure xbrli:shares iso4217:GBP